Connect

An important step forward in the management of sexual dysfunction in patients with depression.

Dr. Kexin Xu’s research focuses on how epigenetic changes drive cancer growth and treatment resistance, with the goal of identifying new therapies.

UVA Benefits Open Enrollment for Plan Year 2027 is Oct. 5-16, 2026.

The results suggest the technology is poised to become an invaluable research tool but needs refinement and close human oversight.

"Unexpected findings can sometimes help us ask better questions," says a UVA School of Medicine researcher.

Epic-integrated patient education, MAR updates for paralytic meds, timekeeping, UVA Health Town Hall